Literature DB >> 12898236

Quantitative reverse transcriptase polymerase chain reaction analysis for KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in hepatocellular carcinoma.

Masahide Ikeguchi1, Yasuaki Hirooka, Nobuaki Kaibara.   

Abstract

PURPOSE: KiSS-1 has been cloned as a human metastasis suppressor gene and an orphan G-protein-coupled receptor (hOT7T175) identified as the endogenous receptor of the KiSS-1 product. In the present study, we evaluated the clinical importance of KiSS-1 and hOT7T175 gene expression in hepatocellular carcinoma (HCC).
METHODS: The expression levels of KiSS-1, hOT7T175 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) messenger RNAs (mRNAs) were analyzed quantitatively by real-time reverse transcriptase polymerase chain reaction (RT-PCR) in 60 surgically resected HCCs. The KiSS-1/GAPDH and hOT7T175/GAPDH ratios of tumors were compared with clinicopathological findings.
RESULTS: Loss of KiSS-1 mRNA expression was not detected in HCCs. The mean KiSS-1/GAPDH ratio did not change between non-cancerous cirrhotic livers and carcinomas. On the other hand, the average hOT7T175/GAPDH ratios increased from non-cancerous livers (0.08) to carcinomas (0.48). Overexpression of KiSS-1 and hOT7T175 genes was recognized in 6 tumors, which were in an advanced stage and showed poor survival.
CONCLUSION: Overexpression of KiSS-1 and hOT7T175 genes was frequently observed and correlated with HCC progression; thus, the possibility that overexpressed KiSS-1 and hOT7T175 peptides mediate growth signals into cancer cells in HCCs is suggested.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12898236     DOI: 10.1007/s00432-003-0469-z

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  15 in total

1.  G2A is an oncogenic G protein-coupled receptor.

Authors:  I E Zohn; M Klinger; X Karp; H Kirk; M Symons; M Chrzanowska-Wodnicka; C J Der; R J Kay
Journal:  Oncogene       Date:  2000-08-10       Impact factor: 9.867

2.  Quantitative reverse transcription-PCR assay of the RNA component of human telomerase using the TaqMan fluorogenic detection system.

Authors:  T Yajima; A Yagihashi; H Kameshima; D Kobayashi; D Furuya; K Hirata; N Watanabe
Journal:  Clin Chem       Date:  1998-12       Impact factor: 8.327

3.  Quantitation of marrow disease in neuroblastoma by real-time reverse transcription-PCR.

Authors:  I Y Cheung; N K Cheung
Journal:  Clin Cancer Res       Date:  2001-06       Impact factor: 12.531

4.  Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells.

Authors:  Matthew D Ringel; Elena Hardy; Victor J Bernet; Henry B Burch; Frank Schuppert; Kenneth D Burman; Motoyasu Saji
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

5.  The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54.

Authors:  M Kotani; M Detheux; A Vandenbogaerde; D Communi; J M Vanderwinden; E Le Poul; S Brézillon; R Tyldesley; N Suarez-Huerta; F Vandeput; C Blanpain; S N Schiffmann; G Vassart; M Parmentier
Journal:  J Biol Chem       Date:  2001-07-16       Impact factor: 5.157

6.  Overexpression of orphan G-protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with beta-catenin mutations.

Authors:  Yoshiya Yamamoto; Michiie Sakamoto; Gen Fujii; Hitomi Tsuiji; Kengo Kenetaka; Masahiro Asaka; Setsuo Hirohashi
Journal:  Hepatology       Date:  2003-03       Impact factor: 17.425

Review 7.  Sex hormones and liver cancer.

Authors:  Nicola De Maria; Mauro Manno; Erica Villa
Journal:  Mol Cell Endocrinol       Date:  2002-07-31       Impact factor: 4.102

8.  Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23.

Authors:  F Shirasaki; M Takata; N Hatta; K Takehara
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

9.  Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans.

Authors:  Yasuko Horikoshi; Hirokazu Matsumoto; Yoshihiro Takatsu; Tetsuya Ohtaki; Chieko Kitada; Satoshi Usuki; Masahiko Fujino
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

10.  Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome.

Authors:  Marta Sanchez-Carbayo; Paola Capodieci; Carlos Cordon-Cardo
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

View more
  31 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function.

Authors:  Helen R Kirby; Janet J Maguire; William H Colledge; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  KiSS-1 expression in human breast cancer.

Authors:  Tracey A Martin; Gareth Watkins; Wen G Jiang
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  Kisspeptin-54 levels are increased in patients with colorectal cancer.

Authors:  Emel Canbay; Arzu Ergen; Dursun Bugra; Sumer Yamaner; Ilhan Yaylim Eraltan; Yilmaz Buyukuncu; Turker Bulut
Journal:  World J Surg       Date:  2012-09       Impact factor: 3.352

4.  Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system.

Authors:  E Votsi; D Roussos; I Katsikis; A Karkanaki; M Kita; D Panidis
Journal:  Hippokratia       Date:  2008       Impact factor: 0.471

5.  KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an immunohistochemical study.

Authors:  Katharina Schmid; Xiaowei Wang; Andrea Haitel; Wolfang Sieghart; Markus Peck-Radosavljevic; Martin Bodingbauer; Susanne Rasoul-Rockenschaub; Fritz Wrba
Journal:  Virchows Arch       Date:  2007-02       Impact factor: 4.064

6.  Q36R polymorphism of KiSS-1 gene in Brazilian head and neck cancer patients.

Authors:  Mariângela Torreglosa Ruiz; Ana Lívia Silva Galbiatti; Erika Cristina Pavarino; José Victor Maniglia; Eny Maria Goloni-Bertollo
Journal:  Mol Biol Rep       Date:  2012-01-01       Impact factor: 2.316

Review 7.  The KISS1 metastasis suppressor: mechanistic insights and clinical utility.

Authors:  Kevin T Nash; Danny R Welch
Journal:  Front Biosci       Date:  2006-01-01

8.  KISS1 receptor is preferentially expressed in clinically non-functioning pituitary tumors.

Authors:  Marianna Yaron; Ulrich Renner; Suzan Gilad; Günter K Stalla; Naftali Stern; Yona Greenman
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

9.  KiSS1/GPR54 and estrogen-related gene expression profiles in primary breast cancer.

Authors:  Katarzyna Jarząbek; Leszek Kozłowski; Robert Milewski; Sławomir Wołczyński
Journal:  Oncol Lett       Date:  2012-01-26       Impact factor: 2.967

10.  Metastin has potential as a suitable biomarker and novel effective therapy for cancer metastasis (Review).

Authors:  Sunao Shoji; Xian Yang Tang; Haruhiro Sato; Yukio Usui; Toyoaki Uchida; Toshiro Terachi
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.